DG
44
4
EMN
50
4
AEE
68
4
JNJ
42
3
UPS
32
-8
TJX
50
3
MET
63
3
VRTX
37
-6
NVDA
59
2
APH
65
-10
EXC
57
4
FLR
48
-14
HAL
30
-10
KMX
65
-3
BK
66
-3
MLM
44
6
CHD
37
13
DRI
58
-3
EIX
29
-10
COST
56
6
DG
44
4
EMN
50
4
AEE
68
4
JNJ
42
3
UPS
32
-8
TJX
50
3
MET
63
3
VRTX
37
-6
NVDA
59
2
APH
65
-10
EXC
57
4
FLR
48
-14
HAL
30
-10
KMX
65
-3
BK
66
-3
MLM
44
6
CHD
37
13
DRI
58
-3
EIX
29
-10
COST
56
6
Financhill
Back

Philip Morris International Vs. Monopar Therapeutics Industry Stock Comparison

Buy
79

PM
Philip Morris International

Last Price:
$184.52
Seasonality Move:
2.9%
Sell
28

MNPR
Monopar Therapeutics

Last Price:
$33.23
Seasonality Move:
-27.37%
Buy
79
Philip Morris International (PM) is a Buy

Is Philip Morris International a Buy, Sell or Hold?

  • The current Philip Morris International [PM] share price is $184.95. The Score for PM is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
  • PM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Monopar Therapeutics (MNPR) is a Sell

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $31.83. The Score for MNPR is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PM Stock Price Chart

What is Philip Morris International's stock price today?

  • The Philip Morris International share price today is $184.95
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PM is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $31.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

PM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.24 Buy
Relative Strength Index (14 RSI): 66.64 Buy
Chaikin Money Flow: 2256122 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (176.19 - 183.87) Buy
Bollinger Bands (100): (146.22 - 176) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.02 Sell
Relative Strength Index (14 RSI): 40.2 Sell
Chaikin Money Flow: -45435 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.39 - 36.35) Sell
Bollinger Bands (100): (31.8 - 43.04) Sell

PM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 183.68 Buy
20-day SMA: 181.66 Buy
50-day SMA: 173.2 Buy
200-day SMA: 143.01 Buy
8-day EMA: 183.28 Buy
20-day EMA: 180.79 Buy
50-day EMA: 173.35 Buy
200-day EMA: 147.16 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.5 Sell
20-day SMA: 33.86 Sell
50-day SMA: 37.1 Sell
200-day SMA: 26.97 Buy
8-day EMA: 33.32 Sell
20-day EMA: 34.29 Sell
50-day EMA: 35.5 Sell
200-day EMA: 28.27 Buy

Philip Morris International Earnings Growth & PM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.97 per share, and an increase next year of $0.80 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.11 per share.

Philip Morris International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):